Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 45 of Inhibikase Therapeutics, Inc.'s SEC filings and found 21 warrant series, 2 ATM programs, 4 shelf registrations and 5 completed offerings on file for IKT. The latest dilution event on file is ATM sales on Jul 31, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ELDNEledon Pharmaceuticals, Inc.
ACIUAC Immune SA
PLXProtalix BioTherapeutics, Inc.
ARTVArtiva Biotherapeutics, Inc.
PALIPalisade Bio, Inc.
SLGLSol-Gel Technologies Ltd. Ordinary Shares
KRROKorro Bio, Inc.
AKBAAkebia Therapeutics, Inc.
ADCTADC Therapeutics SA
PYXSPyxis Oncology, Inc.
RNACCartesian Therapeutics, Inc.
DTILPrecision BioSciences, Inc.
VNDAVanda Pharmaceuticals Inc.
CGENCompugen Ltd
PRQRProQR Therapeutics N.V. Ordinary Shares